News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

A thumb hovers over a cell phone screen lit up with square icons, specifically the white and black ChatGPT
News Release

While generative AI (GenAI) can help define viable objectives for organizational and policy decision-making, the overall quality of those objectives falls short unless humans intervene.

Read More
Four jovial people sit around an outdoor table toasting with a beach and ocean in the background
News Release

Travelers systematically give restaurants higher online ratings than locals do, revealing a “tourist bias” that could distort how diners and platforms interpret online reviews.

Read More
A periwinkle background sees a white box with beveled edges. On it, magnifying glass icons lay to the left of corresponding grey text.
News Release

Prepopulating e-commerce search bars with trending or personalized keywords can meaningfully increase both purchasing and consumer spending. 

Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565

INFORMS in the News

What are you looking for?

Type of Content
Topic
Why We Need A Blue-Collar AI Workforce

Why We Need A Blue-Collar AI Workforce

Forbes, April 1, 2021

The 2020 LinkedIn U.S. Emerging Jobs Reportidentified the top 15 jobs over the previous five years and emphasized that “artificial intelligence and data science roles continue to proliferate across nearly every industry.” Artificial intelligence specialist (No. 1) showed 74% annual growth, and data scientist (No. 3) and data engineer (No. 8) followed with 37% and 33% annual growth.

Walgreens not following U.S. guidance on Pfizer vaccine spacing

Walgreens not following U.S. guidance on Pfizer vaccine spacing

The Seattle Times, April 5, 2021

Walgreens has inoculated hundreds of thousands of Americans against COVID-19 this year using the vaccine developed by Pfizer and Germany’s BioNTech. But the pharmacy chain has not been following guidance from federal health officials about the timing of second doses.

How Alarmed Should We Be About the 15 Million Tossed J&J Vaccines?

How Alarmed Should We Be About the 15 Million Tossed J&J Vaccines?

Slate, April 2, 2021

On Wednesday, Johnson & Johnson acknowledged that a huge batch of vaccines—enough for 15 million doses—had to be tossed out after it was found to have been contaminated during the production process. Soon afterward, several outlets reported that the company producing the vaccine at that Baltimore facility, Emergent BioSolutions, had been cited multiple times before for quality control issues. The sheer number of doses that were discarded, and the idea of a “contamination” of a COVID vaccine, has raised plenty of questions.

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine